期刊文献+

中国部分地区艰难梭菌PCR-核糖体分型及毒素基因多态性研究 被引量:10

PCR ribotyping and toxin gene polymorphism of Clostridium difficile in China
下载PDF
导出
摘要 目的了解中国部分地区艰难梭菌聚合酶链反应(PCR)-核糖体型别分布及其A、B毒素基因多态性,为建立适宜中国的艰难梭菌分子检测和分子分型技术提供基础数据,同时在基因水平上为艰难梭菌感染导致的复杂临床表现提供依据。方法对中国3个城市(北京、广州、济南)分离的64株艰难梭菌临床株进行PCR-核糖体分型,并对不同型别的26株代表菌株的A、B毒素基因进行扩增测序。结果 64株艰难梭菌中,毒素基因型以A+B+型(45株,70.31%)为主,A-B+型19株(29.69%)。共存在9种PCR-核糖体型别,以017型(21株,32.81%)为主要型别,其次为001型(13株,20.31%)、012型(11株,17.19%)。A-B+菌株中,14株(73.68%)是017型,1株是001型。A、B毒素基因呈现一定的多态性,其中有7种A毒素序列型别(TSTA),6种B毒素序列型别(TSTB),8种A、B毒素序列型别组合(TSTG)。结论我国部分地区的艰难梭菌可能以PCR-核糖体017型为主,A、B毒素基因在菌株间存在多态性,且核糖体型别与毒素基因多态性间存在相对应的关联。应进一步扩大菌株数量和范围,探寻适合我国的分子检测和分子分型方法,从而帮助医院更好地预防和控制艰难梭菌感染。 Objective To understand the distribution of PCR ribotyps and toxin gene polymorphism of Clostridi- urn difficile (C. difficile) in some areas of China, provide the reference sequences for the establishment of appro- priate molecular detection and typing methods, and support clinical decision for the complex C. diffcile infections. Methods Sixty-four C. difficile isolates collected from 3 cities(Beijing,Guangzhou,Jinan) were performed PCR-ri- botyping analysis. Among them, tcdA and tcdB of 26 representative strains were amplified and sequenced. Results Among 64 C. difficile isolates, 45 (70. 3 1%) were type A + B +, 19 (29. 69 %) were type A - B +. Nine different PCR ribotypes were obtained. The top 3 ribotypes were 017(21 isolates,32. 81%), 001(13 isolates,20. 31%), and 012(11 isolates,17. 19%). Among A- B+ strains, 14(73. 68~)were ribotype 017, 1 was ribotype 001. Toxin gene sequences showed polymorphism, there were 7 TSTA, 6 TSTB, and 8 TSTG. Conclusion The dominant Chi- nese ribotype may be 017, and toxin genes show certain polymorphism among strains, there is a corresponding rela- tionship between PCR ribotypes and toxin gene polymorphism. Further study will be performed with expanding strains, so as to find appropriate molecular detection and molecular typing method, and help hospitals to prevent andcontrol C. di f ficile infection.
出处 《中国感染控制杂志》 CAS 2014年第1期1-7,共7页 Chinese Journal of Infection Control
基金 国家自然科学基金(No.81101218)
关键词 艰难梭菌 艰难梭状芽孢杆菌 假膜性肠炎 核糖体分型 A毒素基因 B毒素基因 抗生素相关腹泻 医院感染 Clostridium difficile pseudomembranous colitis ribotyping tcdA gene tcdB gene antibiotic-as-sociated diarrhea healthcare-associated infection
  • 相关文献

参考文献20

  • 1Vaishnavi C. Established and potential risk factors for Clostridum difficile infection[J].{H}INDIAN JOURNAL OF MEDICAL MICROBIOLOGY,2009,(4):289-300.
  • 2Chan S,Kelly M,Helme S. Outcomes following colectomy for Clostridium difficile colitis[J].{H}INTERNATIONAL JOURNAL OF SURGERY,2009,(1):78-81.
  • 3Fimlaid K A,Bond J P,Schutz K C. Global analysis of the sporulation pathway of Clostridium difficile[J].{H}PLoS Genetics,2013,(8):e1003660.
  • 4Jung K S,Park J J,Chon Y E. Risk factors for treatment failure and recurrence after metronidazole treatment for Clostridium difficile-associated diarrhea[J].Gut Liver,2010,(3):332-337.
  • 5Bauer M P,Notermans D W,Van Benthem B H. Clostridium difficile infection in Europe:a hospital-based survey[J].{H}LANCET,2011,(9759):63-73.
  • 6Cohen S H,Gerding D N,Johnson S. Clinical practice guidelines for Clostridium difficile infection in adults:2010 update by the society for healthcare epidemiology of America(SHEA)and the infectious diseases society of America(IDSA)[J].{H}Infection Control and Hospital Epidemiology,2010,(5):431-455.
  • 7Kelly C P,Lamont J T. Clostridium difficile-more difficult than ever[J].{H}New England Journal of Medicine,2008,(18):1932-1940.
  • 8Cornely O A,Crook D W,Esposito R. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe,Canada,and the USA:a double-blind,non-inferiority,randomised controlled trial[J].{H}LANCET INFECTIOUS DISEASES,2012,(4):281-289.
  • 9Cheng Y,Du P,Chen C. Toxin A-negative,toxin B-positive Clostridium difficile infection diagnosed by polymerase chain reaction[J].{H}Infection Control and Hospital Epidemiology,2011,(5):520-522.
  • 10Kato H,Kato N,Watanabe K. Identification of toxin A-negative,toxin B-positive Clostridium difficile by PCR[J].{H}Journal of Clinical Microbiology,1998,(8):2178-2182.

二级参考文献10

共引文献199

同被引文献114

  • 1丁维俊,周邦靖,翟慕东,白华.参苓白术散对小鼠脾虚模型肠道菌群的影响[J].北京中医药大学学报,2006,29(8):530-533. 被引量:117
  • 2楼淑瑾.抗生素相关性腹泻相关因素与对策[J].辽宁中医药大学学报,2006,8(6):120-121. 被引量:11
  • 3蒋兆年.肉蔻四神丸治疗抗生素相关性腹泻21例临床观察[J].首都医药,2007,14(11X):44-44. 被引量:7
  • 4Hall IC,O Toole E.Intestinal flora in newborn infants with a description of a new pathogenic anaerobe,Bacillus difficile.Am J Dis Child 1935; 48: 390-402.
  • 5Thomas C,Stevenson M,Riley TV.Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review.J Antimicrob Chemother 2003; 51: 1339-1350.
  • 6Bartlett JG,Chang TW,Gurwith M,Gorbach SL,Onderdonk AB.Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.N Engl J Med 1978; 298: 531-534.
  • 7O'Connor D,Hynes P,Cormican M,Collins E,Corbett-Feeney G,Cassidy M.Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea.J Clin Microbiol 2001; 39: 2846-2849.
  • 8Mutters R,Nonnenmacher C,Susin C,Albrecht U,Kropatsch R,Schumacher S.Quantitative detection of Clostridium difficile in hospital environmental samples by real-time polymerase chain reaction.J Hosp Infect 2009; 71: 43-48.
  • 9Garg S,Mirza YR,Girotra M,Kumar V,Yoselevitz S,Segon A,Dutta SK.Epidemiology of Clostridium difficile-associated disease (CDAD): a shift from hospital-acquired infection to long-term care facility-based infection.Dig Dis Sci 2013; 58: 3407-3412.
  • 10McDonald LC,Coignard B,Dubberke E,Song X,Horan T,Kutty PK.Recommendations for surveillance of Clostridium difficile-associated disease.Infect Control Hosp Epidemiol 2007; 28: 140-145.

引证文献10

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部